FDA committee supports authorization of Moderna’s COVID-19 vaccine
December 17, 2020 at 17:11 PM EST
An independent advisory committee on Thursday voted 20-0-1 that the benefits of Moderna Inc.’s COVID-19 vaccine candidate outweigh the risks, a recommendation that sets the stage for the likely second FDA authorization of a vaccine during the pandemic.
